Targeted inhibitor of mutated KRAS gene shows promise in lung, bowel, & other solid tumors

Adagrasib (MRTX849) achieves objective responses in nearly half of patients with non-small cell lung cancer; Encouraging early results in patients with colorectal, pancreatic, and endometrial cancer Credit: Dana-Farber Cancer Institute A novel agent that targets a mutated form of the KRAS gene – the most commonly altered oncogene in human cancers and one long considered […]

Published on Sun, 25 Oct 2020 15:03:25 +0000 and brought to you by nintex array starts with variable